DK0651741T3 - NG-Monomethyl-L-arginin-hydrochloridderivater og fremgangsmåde til fremstilling deraf - Google Patents

NG-Monomethyl-L-arginin-hydrochloridderivater og fremgangsmåde til fremstilling deraf

Info

Publication number
DK0651741T3
DK0651741T3 DK93917905.7T DK93917905T DK0651741T3 DK 0651741 T3 DK0651741 T3 DK 0651741T3 DK 93917905 T DK93917905 T DK 93917905T DK 0651741 T3 DK0651741 T3 DK 0651741T3
Authority
DK
Denmark
Prior art keywords
preparation
monomethyl
arginine hydrochloride
hydrochloride derivatives
derivatives
Prior art date
Application number
DK93917905.7T
Other languages
Danish (da)
English (en)
Inventor
Harold Francis Hodson
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of DK0651741T3 publication Critical patent/DK0651741T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
DK93917905.7T 1992-07-24 1993-07-23 NG-Monomethyl-L-arginin-hydrochloridderivater og fremgangsmåde til fremstilling deraf DK0651741T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929215816A GB9215816D0 (en) 1992-07-24 1992-07-24 Arginine derivatives

Publications (1)

Publication Number Publication Date
DK0651741T3 true DK0651741T3 (da) 1997-05-12

Family

ID=10719277

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93917905.7T DK0651741T3 (da) 1992-07-24 1993-07-23 NG-Monomethyl-L-arginin-hydrochloridderivater og fremgangsmåde til fremstilling deraf

Country Status (24)

Country Link
EP (1) EP0651741B1 (cs)
JP (1) JP2878844B2 (cs)
KR (1) KR950702528A (cs)
CN (1) CN1087624A (cs)
AT (1) ATE148451T1 (cs)
CA (1) CA2140852A1 (cs)
CY (1) CY2085B1 (cs)
CZ (1) CZ8095A3 (cs)
DE (1) DE69307894T2 (cs)
DK (1) DK0651741T3 (cs)
ES (1) ES2098051T3 (cs)
GB (1) GB9215816D0 (cs)
GR (1) GR3022773T3 (cs)
HU (1) HU210876A9 (cs)
IL (1) IL106463A (cs)
MX (1) MX9304466A (cs)
NO (1) NO302360B1 (cs)
NZ (1) NZ254865A (cs)
PL (1) PL307238A1 (cs)
RU (1) RU95105249A (cs)
SG (1) SG46425A1 (cs)
SK (1) SK8295A3 (cs)
WO (1) WO1994002453A1 (cs)
ZA (1) ZA935348B (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5424447A (en) * 1993-07-07 1995-06-13 The Medical College Of Wisconsin Research Foundation, Inc. Heme binding compounds and use thereof
GB9603522D0 (en) * 1996-02-20 1996-04-17 Wellcome Found Chemical process
AU2004207720A1 (en) * 2003-01-31 2004-08-12 Teijin Pharma Limited Crystal of (23S)-1alpha-hydroxy-27-nor-25-methylenevitamin D3-26,23-lactone and process for producing the same
CN1724514B (zh) * 2004-07-19 2010-06-09 上海依福瑞实业有限公司 一种l－高精氨酸盐酸盐的制备方法
US20100158857A1 (en) * 2006-05-23 2010-06-24 University Of Utah Research Foundation Compositions and methods for the inhibition of endothelial nitric oxide synthase activity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028627A (en) * 1989-09-13 1991-07-02 Cornell Research Foundation, Inc. Method of using arginine derivatives to inhibit systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor

Also Published As

Publication number Publication date
ATE148451T1 (de) 1997-02-15
ZA935348B (en) 1995-01-23
CZ8095A3 (en) 1995-10-18
CY2085B1 (en) 1999-03-05
EP0651741B1 (en) 1997-01-29
KR950702528A (ko) 1995-07-29
HU210876A9 (en) 1995-09-28
NO950248L (no) 1995-01-23
IL106463A (en) 1998-08-16
CA2140852A1 (en) 1994-02-03
DE69307894T2 (de) 1997-06-12
PL307238A1 (en) 1995-05-15
MX9304466A (es) 1994-04-29
CN1087624A (zh) 1994-06-08
AU669557B2 (en) 1996-06-13
NO302360B1 (no) 1998-02-23
GB9215816D0 (en) 1992-09-09
JP2878844B2 (ja) 1999-04-05
GR3022773T3 (en) 1997-06-30
EP0651741A1 (en) 1995-05-10
AU4715793A (en) 1994-02-14
NO950248D0 (no) 1995-01-23
RU95105249A (ru) 1996-10-27
SK8295A3 (en) 1995-07-11
IL106463A0 (en) 1993-11-15
WO1994002453A1 (en) 1994-02-03
JPH07509239A (ja) 1995-10-12
NZ254865A (en) 1996-10-28
DE69307894D1 (de) 1997-03-13
ES2098051T3 (es) 1997-04-16
SG46425A1 (en) 1998-02-20

Similar Documents

Publication Publication Date Title
DE59609501D1 (de) Kristallmodifikation des CDCH, Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
FI960042L (fi) Farmaseuttisia valmisteita niukkaliukoisia aktiivisia aineita varten
FI20030210L (fi) Suun kautta annettavat farmaseuttiset valmisteet sekä menetelmä niiden valmistamiseksi
FI955091A7 (fi) Parannetut farmaseuttisesti hyväksyttävät seokset, jotka sisältävät al koholia ja hydrofobista lääkettä
FI922620A7 (fi) Peptidijohdannainen, menetelmä sen valmistamiseksi, sitä sisältävä far maseuttinen valmiste ja menetelmä glaukooman hoitamiseksi
FI953898A7 (fi) Glysiiniamidijohdannaisia, menetelmiä niiden valmistamiseksi ja niitä sisältäviä lääkeaineita
NO923283L (no) 1,4-benzodioksanderivater, fremgangsmaate for fremstillingderav, samt farmasoeytiske preparater som inneholder minstett slikt derivat
NO305903B1 (no) Benzonitriler og benzofluorider, legemidler bestående av forbindelsene, farmasöytiske preparater inneholdende forbindelsene, samt anvendelse av forbindelsene for fremstilling av farmasöytiske preparater
FI945975L (fi) Haarautuneella aminoryhmällä substituoituja tiatsoleja, menetelmiä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia
NO931527D0 (no) Cykliske iminoderivater, medisinpreparater inneholdende disse, og fremgangsmaate for deres fremstilling
EE04371B1 (et) Fenüülamidiini derivaadid, meetodid nende valmistamiseks ja nende kasutamine arstimitena
DK0651741T3 (da) NG-Monomethyl-L-arginin-hydrochloridderivater og fremgangsmåde til fremstilling deraf
FI951961L (fi) Tilidiinidivetyortofosfatti, menetelmä sen valmistamiseksi ja sitä sisältäviä farmaseuttisia valmisteita
NO930796D0 (no) Glykopeptidderivater, fremgangsmaate for deres fremstilling og farmasoeytiske midler inneholdende disse
EP0515995A3 (en) N-(5-thioxo-l-prolyl)-l-cysteine, derivatives thereof, processes for the preparation thereof and pharmaceutical compositions containing them
FI945729L (fi) Aminosubstituoidut bentseenisulfonyyliureat ja -tioureat, menetelmä niiden valmistamiseksi ja niiden käyttö farmaseuttisina aineina
DE69318153D1 (de) Antihypercholesterämisch-wirksame verbindungen, pharmazeutische präparate und verwendungen davon
GEP20012518B (en) Novel Erythromycin Derivatives, Method for Their Preparation and Their Use as Medicine
FI946136A7 (fi) Substituoidut bentseenisulfonyylivirtsa-aineet ja -tiovirtsa-aineet, niiden valmistusmenetelmät ja näihin yhdisteisiin perustuvien farmaseuttisten valmisteiden käyttö
NO305792B1 (no) Substituerte benzensulfonylureaer, deres anvendelse for fremstilling av farmas°ytiske preparater og medikamenter inneholdende disse
GR3019776T3 (en) Antineoplastic medicament containing octadecyl-[2-(N-methylpiperidino)-ethyl] phosphate and synthesis thereof
DK155692D0 (da) Benzofuranylimidazolderivater, fremgangsmaade til deres fremstilling og farmaceutiske praeparater indeholdende disse
ZA913171B (en) 1,5-benzothiazepinone derivatives,their preparations and pharmaceutical use
AU8744691A (en) N-((2-thenoylmercapto-3-methyl)-butanoyl)-homocysteine thiolactone, a process for the preparation thereof and pharmaceutical compositions containing it
NO924145D0 (no) Sammensetning for faste, farmasoeytiske preparater inneholdende vitamin d3-derivat, og fremgangsmaate for fremstilling derav